The fund owned 14,649 shares of the biotechnology company’s stock after selling 797 shares during the period. FTB Advisors Inc.’s holdings in …
The fund owned 14,649 shares of the biotechnology company’s stock after selling 797 shares during the period. FTB Advisors Inc.’s holdings in …
Puma Biotechnology logo Shares of Puma Biotechnology Inc. (NYSE:PBYI) have been assigned a consensus recommendation of âBuyâ from the ten …
Puma Biotechnology, Inc. (NYSE:PBYI) stock is presently standing at about $36.50 and lots of equity research firms seem to have a target price set on …
Puma Biotechnology, Inc.’s (PBYI) witnessed a gain of 0.14% in recent trading period with closing price of $ 36.50. The company’s last traded volume …
According to Zacks, âBioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform …
Lion Biotechnologies Inc. (NASDAQ:LBIO) â FBR & Co issued their FY2018 earnings estimates for shares of Lion Biotechnologies in a research report …
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human …
Biogen’s initial share price surge helped to lift the bio biotech exchange-traded funds at a clip that dramatically outpaced the broader market.
It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert …
Lion Biotechnologies logo Victory Capital Management Inc. bought a new position in shares of Lion Biotechnologies Inc. (NASDAQ:LBIO) during the …